# AGY Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/agy-therapeutics

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Total disclosed funding: $9M
- Latest round: Series C (Apr 7, 2004)
- Investors on record: 6

## About

Based in California, US, and founded in 1998, AGY Therapeutics, Inc. is a biopharmaceutical company focused on research and development into the treatment of stroke patients.

## Funding rounds

- Series C, Apr 7, 2004, $9M — Alta Partners, HBM Partners, Novartis Venture Fund, Daiwa Corporate Investment, GE Commercial Finance, JAFCO Group

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series C
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series C
- GE Commercial Finance — Series C
- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series C